外源性眼内炎23G微创玻璃体切除术疗效  

Efficacy of 23-gauge minimally invasive vitrectomy for exogenous endophthalmitis

作　　者：刘刚[1] 张春娣[1] 张淑萍 贾万程[1] 

机构地区：[1]上海交通大学附属第六人民医院南院眼科,上海201400

出　　处：《中华眼外伤职业眼病杂志》2017年第11期826-829,共4页Chinese Journal of Ocular Trauma and Occupational Eye Disease

摘　　要：目的分析外源性眼内炎23G微创玻璃体切除术疗效。方法回顾性研究2008年5月至2016年5月外源性感染性眼内炎105例（105眼）。患者均经局部及全身予足量抗菌药物及玻璃体注药术或23G微创玻璃体切除术治疗。治疗后随访1～6个月，分析其治疗效果和并发症。结果治愈97例，占92．38％，其中玻璃体切除术联合药物辅助治疗57例（54．29％），术中无医源性裂孔等并发症发生。术后末次随访时，最佳矫正视力优于术前，差异有统计学意义（P〈0．05）；眼压与术前比较，差异无统计学意义（P〉0．05）。结论23G微创玻璃体切除术治疗外源性眼内炎安全有效。Objective To analyze the efficacy of 23 G minimally invasive vitrectomy for exogenous endophthalmitis. Methods A retrospective case series study. The data of 105 eyes of 105 patients with exogenous infectious endophthalmitis from May 2008 to May 2016 were analyzed. All cases received local and systemic sufficient antibiotics treatment, intravitreal injection or 23 G minimally invasive vitrectomy. Follow-up time was 1 - 6 months after treatment. The efficacy and complications of 23 G vitreetomy were analyzed. Results Among 105 cases, endophthalmitis were cured in 97 cases （ 92. 38% ）, in which vitrectomy combined with antibiotics adjuvant therapy were received in 57 eases, accounting for 54.29%. No iatrogenic retinal tear occurred. At the end of follow-up, BCVA were improved after surgery, the difference was statistically significant between before and after surgery（ P 〈 0.05 ）. There was no statistically difference in intraoeular pressure between before and after surgery （ P 〉 0. 05 ）. Conclusion The 23-gauge minimally invasive vitreetomy is safe and effective for exogenous endophthalmitis.

关 键 词：眼内炎 外源性 玻璃体切除术 微创 

分 类 号：R779.6[医药卫生—眼科]